You are on Trendlyne United States. Click here to go to India website or make United States as your default

267.34 -2.44 (-0.90%)

34.23% Fall from 52W High

1.5M XNYS Volume

XNYS 19 Mar, 2025 5:30 PM (EDT)

Dividend
Humana Inc. has an upcoming dividend of $0.88 per share due on 28 Mar 2025 See details

Humana Inc. Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Medium Financial Strength
38.9 / 100
Mid Valuation
43.3 / 100
Technically Neutral
39.3 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

Humana Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2675k100k125k150kActual RevenueAvg. Estimate
Hit

Humana Inc.'s Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
10
Avg. Estimate
16
Low Estimate
15.7
High Estimate
16.7
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 59.9% in FY25

Consensus Recommendation

26 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.218Hold3Buy5Strong Buy

The consensus recommendation from 26 analysts for Humana Inc. is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Humana Inc. Stock Analysis

Humana Inc. stock analysis with key metrics, changes, and trends.

Humana Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$117,761 M10.7%positive

Annual Revenue rose 10.7%, in the last year to $117,761 M. Its sector's average revenue growth for the last fiscal year was 7.96%.

Annual Net Profit$1,207 M51.51%negative

Annual Net Profit fell 51.51% in the last year to $1,207 M. Its sector's average net profit growth for the last fiscal year was 2.74%.

Price to Earning Ratio26.73-negative

Price to Earning Ratio is 26.73, higher than its sector PE ratio of 24.23.

Stock Price$267.34-23.96%negative

Stock Price fell 23.96% and underperformed its sector by 27.87% in the past year.

Quarterly Revenue$29,213 M10.4%positive

Quarterly Revenue rose 10.4% YoY to $29,213 M. Its sector's average revenue growth YoY for the quarter was 9.31%.

Quarterly Net profit$693 M28.1%negative

Quarterly Net profit fell 28.1% YoY to $693 M. Its sector's average net profit growth YoY for the quarter was 36.39%.

Debt to Equity Ratio0.72-positive

Debt to Equity Ratio of 0.72 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)7.40 %7.4%negative

Return on Equity(ROE) for the last financial year was 7.4%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding77.73 %4.49%positive

Mutual Fund Holding increased by 4.49% in the last quarter to 77.73.

Interest Coverage Ratio3.61-positive

Interest Coverage Ratio is 3.61, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding97.38 %-0.05%negative

Institutional Holding decreased by 0.05% in the last quarter to 97.38.

VIEW LESS


Loading data..

Humana Inc. - Company Profile

What does Humana Inc. do?

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana Inc. Management structure

All Gross Remunerations are in USD
Mr. David E. Dintenfass
President, Enterprise Growth
18.06 M
2024
Gross Remuneration
Year
Mr. James A. Rechtin
Director, President and Chief Executive Officer
15.58 M
2024
Gross Remuneration
Year
Mr. Bruce D. Broussard
Director and Chief Executive Officer
12.06 M
2024
Gross Remuneration
Year
Ms. Susan M. Diamond
Chief Financial Officer
9.62 M
2024
Gross Remuneration
Year
Dr. Sanjay K. Shetty, M.D.
President, CenterWell
6.44 M
2024
Gross Remuneration
Year
Mr. George Renaudin, II
President, Insurance
6.15 M
2024
Gross Remuneration
Year

Humana Inc. Board of directors

All Gross Remunerations are in USD
Mr. Kurt J. Hilzinger
Chairman of the Board
609.4 K
2024
Gross Remuneration
Year
Ms. Karen W. Katz
Independent Director
388.3 K
2024
Gross Remuneration
Year
Dr. Wayne A.I. Frederick, M.D.
Independent Director
387.26 K
2024
Gross Remuneration
Year
Mr. Frank A. D'Amelio
Independent Director
367.86 K
2024
Gross Remuneration
Year
Mr. Jorge S. Mesquita
Independent Director
366.61 K
2024
Gross Remuneration
Year
Ms. Marcy S. Klevorn
Independent Director
363.59 K
2024
Gross Remuneration
Year

Humana Inc. FAQ

How is Humana Inc. today?
Humana Inc. today is trading in the red, and is down by -0.90% at 267.34.
Humana Inc. is currently trading down -0.90% on an intraday basis. In the past week the stock rose 7.32%. stock has been up 13.39% in the past quarter and fell -23.96% in the past year. You can view this in the overview section.